Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Blueberries Medical Corp. (C:BBM)

Business Focus: Pharmaceuticals (NEC)

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 885 West Georgia Street
Suite 2200, HSBC Building
Tel: N/A
IR: See website
Key People
Business Overview
Blueberries Medical Corp. (Blueberries) is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the cultivation and development of medicinal cannabis and related products. The Company is specialized in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries also licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis.
Financial Overview
For the nine months ended 30 September 2021,Blueberries Medical Corp revenues increased from C$40K toC$174K. Net loss decreased 64% to C$1.3M. Revenues reflectan increase in demand for the Company's products andservices due to favorable market conditions. Lower net lossreflects Share based compensation decrease from C$837K(expense) to C$390K (income), Director and management feesdecrease of 72% to C$105K (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $10.20M as of Sep 30, 2021
Annual revenue (TTM): $0.20M as of Sep 30, 2021
EBITDA (TTM): -$1.16M as of Sep 30, 2021
Net annual income (TTM): -$2.70M as of Sep 30, 2021
Free cash flow (TTM): -$1.70M as of Sep 30, 2021
Net Debt Last Fiscal Year: N/A
Shares outstanding: 163,810,263 as of Sep 30, 2021
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization